Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue    
Capitation, net $ 85,905,284 $ 64,716,133
Risk pool settlements and incentives 17,986,736 11,137,200
Management fee income 12,074,572 6,537,110
Fee-for-service, net 7,748,109 2,663,913
Other income 452,026 281,706
Total revenue 124,166,727 85,336,062
Expenses    
Cost of services 84,670,608 59,607,514
General and administrative expenses 11,735,898 5,211,633
Depreciation and amortization 5,058,512 4,836,351
Total expenses 101,465,018 69,655,498
Income from operations 22,701,709 15,680,564
Other income (expense)    
(Loss) income from equity method investments (28,024) 2,227,262
Interest expense (85,001) (811)
Interest income 269,818 182,285
Change in fair value of derivative instrument 0 1,522,222
Other income 87,993 1,514
Total other income, net 244,786 3,932,472
Income before provision for income taxes 22,946,495 19,613,036
Provision for income taxes 7,228,840 7,889,245
Net income 15,717,655 11,723,791
Net income attributable to noncontrolling interests 13,557,200 7,374,130
Net income attributable to Apollo Medical Holdings, Inc. $ 2,160,455 $ 4,349,661
Earnings per share - basic $ 0.07 $ 0.17
Earnings per share - diluted $ 0.06 $ 0.15
Weighted average shares of common stock outstanding - basic 32,421,467 25,067,954
Weighted average shares of common stock outstanding - diluted 38,098,373 28,445,647